SE352083B - - Google Patents
Info
- Publication number
- SE352083B SE352083B SE12864/70A SE1286470A SE352083B SE 352083 B SE352083 B SE 352083B SE 12864/70 A SE12864/70 A SE 12864/70A SE 1286470 A SE1286470 A SE 1286470A SE 352083 B SE352083 B SE 352083B
- Authority
- SE
- Sweden
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J19/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 by a lactone ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DEF0052707 | 1967-06-16 | ||
| DEF0053332 | 1967-08-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE352083B true SE352083B (en:Method) | 1972-12-18 |
Family
ID=25977626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE12864/70A SE352083B (en:Method) | 1967-06-16 | 1968-06-17 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US3574198A (en:Method) |
| AT (1) | AT312820B (en:Method) |
| BE (1) | BE716698A (en:Method) |
| CH (2) | CH580643A5 (en:Method) |
| DK (1) | DK120948B (en:Method) |
| FR (1) | FR1583914A (en:Method) |
| GB (1) | GB1236822A (en:Method) |
| NL (1) | NL6808141A (en:Method) |
| SE (1) | SE352083B (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020231837A1 (en) | 2019-05-10 | 2020-11-19 | Brii Biosciences, Inc. | Pharmaceutical composition containing brexanolone, ganaxolone, or zuranolone, and use thereof |
| WO2021142477A1 (en) * | 2020-01-12 | 2021-07-15 | Brii Biosciences, Inc. | Neuroactive steroids and pharmaceutical composition containing the same |
-
1968
- 1968-06-10 NL NL6808141A patent/NL6808141A/xx unknown
- 1968-06-11 US US735964A patent/US3574198A/en not_active Expired - Lifetime
- 1968-06-13 CH CH466571A patent/CH580643A5/xx not_active IP Right Cessation
- 1968-06-13 CH CH876468A patent/CH571542A5/xx not_active IP Right Cessation
- 1968-06-14 AT AT568468A patent/AT312820B/de not_active IP Right Cessation
- 1968-06-14 DK DK281568AA patent/DK120948B/da unknown
- 1968-06-17 FR FR1583914D patent/FR1583914A/fr not_active Expired
- 1968-06-17 SE SE12864/70A patent/SE352083B/xx unknown
- 1968-06-17 GB GB28682/68A patent/GB1236822A/en not_active Expired
- 1968-06-17 BE BE716698D patent/BE716698A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FR1583914A (en:Method) | 1969-12-05 |
| AT312820B (de) | 1974-01-25 |
| NL6808141A (en:Method) | 1968-12-17 |
| GB1236822A (en) | 1971-06-23 |
| DE1618437A1 (de) | 1970-10-29 |
| DE1668009A1 (de) | 1971-07-15 |
| BE716698A (en:Method) | 1968-12-17 |
| CH580643A5 (en:Method) | 1976-10-15 |
| DE1618437B2 (de) | 1976-01-02 |
| US3574198A (en) | 1971-04-06 |
| DE1668009B2 (de) | 1975-11-13 |
| CH571542A5 (en:Method) | 1976-01-15 |
| DK120948B (da) | 1971-08-09 |